Clinical Trials on Solid Malignancy in Canada
Total 595 results
-
NCIC Clinical Trials GroupNexstar PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Neurogene Inc.Merck Sharp & Dohme LLCActive, not recruitingSolid Tumor | Advanced Solid TumorUnited States, Australia, Canada
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesFrance, Spain, Canada
-
NCIC Clinical Trials GroupCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Lawson Health Research InstituteLondon Health Sciences CentreCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
NCIC Clinical Trials GroupCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Japan, Canada
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Belgium, Denmark, Canada
-
Maisonneuve-Rosemont HospitalCanadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaboratorsCompletedHematologic MalignancyCanada
-
Alberta Health servicesUnknownHematologic MalignancyCanada
-
Bristol-Myers SquibbCompletedAdvanced Solid CancersUnited States, Canada
-
Boehringer IngelheimRecruitingSolid TumorsSpain, Canada, United States, Sweden
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
Bristol-Myers SquibbCompletedCancer (Solid Tumors)United Kingdom, United States, Canada
-
Gilead SciencesRecruitingSolid TumorsAustralia, United States, Canada
-
Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, Canada, Switzerland
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome...TerminatedAdvanced Solid TumorsUnited States, Canada
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Canada, United Kingdom
-
BayerCompletedAdvanced CEACAM6-expressing Solid TumorsUnited States, Singapore, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada, United States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant MesotheliomaCanada
-
University Health Network, TorontoCompletedMalignant Pleural EffusionsCanada
-
Merck Sharp & Dohme LLCRecruitingNeoplasms | Advanced/Metastatic Solid TumorsCanada, Israel, United States, Netherlands
-
Triumvira Immunologics, Inc.RecruitingMetastatic Solid TumorUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada
-
Alethia BiotherapeuticsCompletedSolid Tumor | Metastatic CancerCanada
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Merck Sharp & Dohme LLCCompletedSolid NeoplasmsUnited States, Canada, Israel, Korea, Republic of
-
McMaster UniversityActive, not recruitingSurgical Procedure, Unspecified | Genital Neoplasm Malignant FemaleCanada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Australia, Belgium, Denmark, Canada
-
PharmaMatrix Holdings LtdUniversity of AlbertaRecruitingCancer: Recurrent and/or Metastatic Solid TumoursCanada
-
Hoffmann-La RocheRecruitingSolid TumorsBelgium, Denmark, Spain, Canada, Netherlands, Poland
-
Sunnybrook Health Sciences CentreGenomic Health®, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastCanada
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
Novartis PharmaceuticalsCompletedA Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsSolid TumorsSpain, Italy, United States, Canada
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Hematopoietic and Lymphatic System NeoplasmUnited States, Canada, Puerto Rico
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Netherlands, Denmark, Spain, Canada, France
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Australia, Canada, New Zealand
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
The Hospital for Sick ChildrenTerminatedMetabolic Disease | Genetic Disorder | MalignancyCanada
-
Raewyn BroadyUnknown
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada